Literature DB >> 20214143

Serum folate and vitamin B12 status in healthy Iranian adults.

M Shams1, K Homayouni, G R Omrani.   

Abstract

To assess the serum folate and vitamin B12 status in healthy Iranian adults, we designed a population-based cross-sectional study of 1200 individuals aged 20-80 years. Finally 984 participants (507 men and 477 women) were assessed. The mean serum folate was 4.61 (SD 2.40) ng/mL and the mean serum vitamin B12 level was 265.6 (SD 170.9) pg/mL. Overall 1.0% were folate deficient and 25.8% had low vitamin B12 levels according to the manufacturer's reference ranges (folate < 1.5 ng/mL and vitamin B12 < 160 pg/mL). The mean serum folate and vitamin B12 levels were significantly lower in men. The prevalence of vitamin B12 deficiency was considerably higher than folate deficiency. Implementation of preventive measures seems to be necessary.

Entities:  

Mesh:

Year:  2009        PMID: 20214143

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Relationship between vitamin B12, folate and homocysteine levels and H. pylori infection in patients with functional dyspepsia: a cross-section study.

Authors:  Shahid Rasool; Shahab Abid; Mohammad Perwaiz Iqbal; Naseema Mehboobali; Ghulam Haider; Wasim Jafri
Journal:  BMC Res Notes       Date:  2012-04-30

2.  Establishing Ghanaian adult reference intervals for hematological parameters controlling for latent anemia and inflammation.

Authors:  Abigail S A Bawua; Kiyoshi Ichihara; Rosemary Keatley; John Arko-Mensah; Yvonne Dei-Adomakoh; Patrick F Ayeh-Kumi; Rajiv Erasmus; Julius Fobil
Journal:  Int J Lab Hematol       Date:  2020-09-03       Impact factor: 2.877

3.  Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study.

Authors:  Jill Benson; Christine Phillips; Margaret Kay; Murray T Webber; Alison J Ratcliff; Ignacio Correa-Velez; Michelle F Lorimer
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.